Skip to main content

RT @KDAO2011: We have great options all around! Both are efficacious in biologic (TNFi) failures for RA patients. Compa

Social Author Name
k dao
Tweet Content
We have great options all around! Both are efficacious in biologic (TNFi) failures for RA patients. Comparative Clinical Efficacy of Sarilumab versus Upadacitinib over 12 Weeks: Matching-Adjusted Indirect Comparison Analysis Abst#0827 #ACR20 @RheumNow https://t.co/1SsL9qLJD3
Show on Archive Page
On
Display in Search Results
On